Drugs / IBC0966
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT04980690 | Aug 2021 → Dec 2024 | cancer | SUNHO（China）BioPharmaceutical CO., Ltd. | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | IBC0966 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04980690 ↗ |